Skip to content

Vallexa Advisors

Leaders in Healthcare Mergers & Acquisitions

Toggle menu
  • Healthcare Agencies for Sale Nationwide
  • Buyer Resources
    • Buyer Credibility Engine Package
    • Join Our Buyer Network
    • Healthcare Agencies for Sale Nationwide
  • Healthcare M&A Blog
  • Selling A Business
    • Seller Learning Center
      • Prepare for Your Exit
      • Set an Asking Price
      • Attract Buyers
      • Negotiating Strategies
      • Finalize the Deal
    • Seller FAQ’s
      • The Business Selling Process: A Step-by-Step Guide
    • Schedule a Free Consultation
    • Successful Healthcare Transactions
  • Business Valuations
    • Explore your Valuation Options
    • How to Value Your Healthcare Business
      • The Hospice Valuation Process: Understanding the Key Factors that Determine Your Business’s Worth
    • Quick Valuation Calculator
    • Grow Your Business
      • Business Boost Web Presence Package
      • Value Builder System
      • Small Business Loans
        • Business Financing
          • SBA Loans
          • Small Business Loans
  • Contact
  • Industries
    • Home Care Business Valuation & Selling Guide (Private Duty / Non-Medical)
    • Home Health Agency Valuation
    • Hospice Valuation & Sale Process
    • Dental Practice Valuation & DSO Sale
    • RCM / Medical Billing Company Valuation
    • HRT & Longevity Clinic Valuation
    • Clinical Research Site Valuation & Sale Process
    • Infusion Center Valuation & Sale Process
    • Med Spa Valuation & Sale Process
    • Behavioral Health Practice Valuation & Sale Process

Author:

Jason A. Atty is Managing Director of Vallexa Advisors. He oversees the firm's offices and leads negotiations on every transaction through closing. He has more than 18 years of experience in mergers and acquisitions, is a Certified Value Builder, and has advised companies valued from $5 million to $100 million. Connect with Jason on LinkedIn.
Photo for Minnesota Hospice for Sale - CHAP Accredited, Statewide License

Minnesota Hospice for Sale – CHAP Accredited, Statewide License

CASH BUYERS ONLY with hands-on hospice experience. Medicare and Medicaid certified, CHAP-accredited Minnesota hospice licensed for the entire state. 36 Month Rule exempt, license-only sale, no CAP, ready to bill. $399,000. Ref #9926582988.

Read more
Illustration showing healthcare professionals and hospice valuation metrics, representing Vallexa Advisors’ expert guide on maximizing hospice agency value.

Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth

Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.

Read more
Selling a hospice in 2026: the public quality file buyers read before they call you. One in five hospices non compliant with CMS quality reporting, Care Compare icon from FY 2028, hospice cap 36,174.75 dollars from October 1, MedPAC March 2026.

Selling a Hospice in 2026: The Quality File Buyers Read Before They Call You

One in five hospices failed CMS quality reporting again in FY 2026, and the FY 2027 final rule adds a public warning icon on Care Compare keyed to this year’s data. What a buyer reads before the first call, and the ninety-day review that fixes it.

Read more

Two Clocks for Owners: October 1 Rates and the Freeze Decision Window

For owners weighing an exit: FY 2027 hospice rates hit Oct 1, 2026. CMS still lists the HHA/hospice enrollment freeze active toward mid-November.

Read more
Vallexa Advisors card reading The Home Health Margin Gap, with Medicare fee for service margin 21.2 percent and all payer margin 5.0 percent, sourced to MedPAC March 2026.

Selling a Home Health Agency in 2026: The Margin Gap Buyers Price First

MedPAC reports a 21.2 percent fee for service Medicare margin for freestanding home health agencies and a 5.0 percent all payer margin for the same agencies. Here is what that gap is made of, why Medicare Advantage widened it, and what to document before you go to market.

Read more
Vallexa Advisors branded card reading Your Associate Bench Is The Asset, noting 36,276 veterinary practices and about 3,100 veterinarian openings a year.

Selling a Veterinary Practice in 2026: Why Your Associate Bench Is the Asset

Roughly 36,000 veterinary practices, roughly 3,100 veterinarian openings a year. Doctor capacity is the binding constraint, which is why a buyer prices your associate bench before almost anything else.

Read more
Vallexa Advisors branded card reading Why Client Concentration Decides Your Price, noting coding roles up 7.8 percent to 2035 and billing clerk roles flat.

Selling a Medical Billing or RCM Company in 2026: Why Client Concentration Decides Your Price

Client concentration is the first number a buyer computes in an RCM deal. What it does to deal structure, which four contract clauses decide the outcome, and what the federal data says about which half of your workforce is growing.

Read more
Vallexa Advisors branded card reading What Your Dental Payer Mix Is Worth, with the figures 38.3 percent out of pocket versus 10.5 percent for health care overall.

Selling a Dental Practice in 2026: What Your Payer Mix Is Actually Worth

Dental is 38.3 percent out of pocket against 10.5 percent for health care overall. Here is what each payer dollar is worth to a buyer, why PPO write-offs decide the negotiation, and what to document before you go to market.

Read more

Selling a Behavioral Health Practice in 2026: What Telehealth Does to Your Valuation

The DEA telemedicine flexibilities for controlled medications expire December 31, 2026. Here is which part of a behavioral health practice is exposed, which part is not, and the four telehealth questions every buyer now asks.

Read more

Selling a Home Care Agency in 2026: The Overtime Rule That Could Reprice Your Business

The Department of Labor has moved its rescission of the 2013 Home Care Rule to the final rule stage. Here is what a change to caregiver overtime would do to a home care agency P and L, why your state may make it irrelevant, and how buyers price an unresolved rule.

Read more

Posts pagination

1 2 … 7 >

Site Map

  • Healthcare Agencies for Sale Nationwide
  • Buyer Resources
    • Buyer Credibility Engine Package
    • Join Our Buyer Network
    • Healthcare Agencies for Sale Nationwide
  • Healthcare M&A Blog
  • Selling A Business
    • Seller Learning Center
      • Prepare for Your Exit
      • Set an Asking Price
      • Attract Buyers
      • Negotiating Strategies
      • Finalize the Deal
    • Seller FAQ’s
      • The Business Selling Process: A Step-by-Step Guide
    • Schedule a Free Consultation
    • Successful Healthcare Transactions
  • Business Valuations
    • Explore your Valuation Options
    • How to Value Your Healthcare Business
      • The Hospice Valuation Process: Understanding the Key Factors that Determine Your Business’s Worth
    • Quick Valuation Calculator
    • Grow Your Business
      • Business Boost Web Presence Package
      • Value Builder System
      • Small Business Loans
        • Business Financing
          • SBA Loans
          • Small Business Loans
  • Contact
  • Industries
    • Home Care Business Valuation & Selling Guide (Private Duty / Non-Medical)
    • Home Health Agency Valuation
    • Hospice Valuation & Sale Process
    • Dental Practice Valuation & DSO Sale
    • RCM / Medical Billing Company Valuation
    • HRT & Longevity Clinic Valuation
    • Clinical Research Site Valuation & Sale Process
    • Infusion Center Valuation & Sale Process
    • Med Spa Valuation & Sale Process
    • Behavioral Health Practice Valuation & Sale Process

Listings by Category

© 2026 Vallexa Advisors. Proudly powered by Sydney
Call Now